EASL Podcasts

This EASL Studio Midday Talks was live broadcast during the EASL Congress 2023 and discusses the newly released EASL policy statement on alcohol harm and related liver diseases. The document aims to highlight the extensive harm resulting from alcohol consumption and shine a light on the effective, yet underused, harm reduction policies available to European countries. Faculty Frank Murray Ireland...

This EASL Studio Good Morning Vienna was live broadcast during the EASL Congress 2023 and is presenting the highlights of liver cancer research at the congress. Faculty Jean-Charles Nault (Moderator) Josep Llovet (Moderator) Jessica Zucman-Rossi (Faculty) Bruno Sangro (Faculty) Matthias Pinter (Faculty) All EASL Studio Podcasts are available on EASL Campus .

This EASL Studio Closing was live broadcast during the EASL Congress 2023 and discusses the future of hepatology. Faculty Thomas Berg (Moderator) Aleksander Krag (Moderator) Tobias Böttler (Faculty) Debbie Shawcross (Faculty) All EASL Studio Podcasts are available on EASL Campus .

In honour of International NASH Day , the final episode of EASL Studio season 4 is shedding light on non-alcoholic steatohepatitis (NASH), a disease with increasing global prevalence but low awareness. Faculty Zobair Younossi (Moderator) Alina M. Allen (Faculty) Sven Francque (Faculty) Vincent Wong (Faculty) Shira Zelber-Sagi (Faculty) All EASL Studio Podcasts are available on EASL Campus .

Non-alcoholic steatohepatitis (NASH) is rapidly emerging as a leading cause of chronic liver disease, presenting significant challenge due to the limited treatment options available. This EASL Studio JHEP Live aims to explore novel and promising treatments currently being evaluated for the treatment of NASH. In particular: ARO-HSD, an HSD17β13 inhibitor. PXL065 under evaluation in the DESTINY-1 tr...

Clinical evidence indicates that cigarette smoking negatively impacts the incidence and severity of fatty liver disease, fibrosis progression, hepatocellular carcinoma development, and the outcomes of patients with advanced liver disease. The underlying mechanisms are complex and involve different pathophysiological pathways including oxidative stress and oncogenic signals. To coincide with World...

Collaborations are key in achieving scientific progress. The European Horizon COST Actions provide great opportunities to build, grant, and/or participate in pan-European collaborations in multidisciplinary topics, including liver diseases. This EASL Studio: Provides you with information about the COST Action programme. Discusses the structure of the drug-induced liver injury (DILI) and cholangioc...

On 22 May 2023, policymakers, thought leaders, Permanent Mission Representatives to the UN, WHO staff, and people affected by liver disease will gather at the EASL Office in Geneva for the invitation-only event on the side-lines of the 76th World Health Assembly*: “Together for Better Liver Health: Mobilising Action for Fatty Liver Disease”. The aim of the event is to raise awareness on the need f...

Hepatitis D is the most severe form of viral hepatitis infection, but fortunately, new treatments are on the horizon. This EASL Studio discusses: Which patients should be treated. Currently available treatment options. Treatment combinations and duration. New treatments in development. Faculty Prof. Heiner Wedemeyer (Moderator) Prof. Soo Aleman (Faculty) Prof. Pietro Lampertico (Faculty) Related e...

International Nurses Day, 12 May, commemorates the birth of Florence Nightingale, considered to be the founder of modern nursing. EASL Studio is taking this opportunity to highlight the important role of nursing in the care of people with liver disease. Faculty Dr Kathryn Jack (Moderator) Mrs Michelle Clayton (Faculty) Mrs Núria Fabrellas (Faculty) Mrs Denise Schäfer (Faculty) Dr Patrizia Künzler-...

Although a longstanding recommendation, the use of albumin as an effective treatment for patients with cirrhosis and ascites has come under scrutiny with recently published studies creating confusion. This EASL Studio discusses, recent results from the MACHT, ATTIRE and PRECIOSA studies and try to shed some light on this controversial topic. Faculty Prof. Alastair O’Brien (Moderator) Prof. Aleksan...

Watch this EASL Studio for highlights from the Liver Cancer Summit 2023 . Discover: How artificial Intelligence is being used to increase knowledge in the field of liver cancer. New markers in hepatocellular carcinoma beyond ultrasound. Updates in the field cholangiocarcinoma and rare liver diseases … and much more! Faculty Prof. Mathias Heikenwälder (Moderator) Prof. Josep Llovet (Faculty) Prof....

Wilson’s disease is a rare autosomal recessive disorder of copper metabolism which is characterised by hepatic and neurological disease This episode of EASL Studio will: Cover the difficulties in diagnosing Wilson’s disease. Discuss treatment options and strategies. Explore the challenges faced by patients with Wilson’s disease. Faculty Prof. Emmanuel Tsochatzis (Moderator) Dr Wiebke Papenthin (Pa...

The EASL Policy Statement on liver cancer screening has recently been updated . In addition to addressing the updates, this episode of EASL Studio will discuss how risk-based surveillance of hepatocellular carcinoma (HCC) in patients suffering from cirrhosis is a cost effective strategy to increase benefits, reduce the harm of HCC surveillance. Faculty Prof. Thomas Berg (Moderator) Mr. Pietro Fioc...

Through widespread multidisciplinary collaboration, consortia and EU grants provide unique opportunities to address critical questions. What opportunities exist for early career scientist? Which elements are essential for success? How have these partnerships contributed to advancements in the field? Watch this episode of EASL Studio to find out. Faculty Prof. Thomas Berg (Moderator) Prof. Rajiv Ja...

The topic of liver transplantation for alcohol-related hepatitis is controversial. While some experts still recommend 6 months of alcohol abstinence before considering transplantation others advocate for early transplantation. Watch this episode to: Understand the epidemiology of alcohol-related hepatitis. Know which treatment options are available to these patients Find out which patients may ben...

Liver biopsy has long been the gold standard for diagnosing NAFLD and NASH. However, it is an invasive  procedure that may not always be necessary. This episode of EASL Studio explored methods for screening, staging, and monitoring disease progression. Faculty Prof. Philip Newsome (Moderator) Prof. Laurent Castera (Faculty) Prof. Maja Thiele (Faculty) All EASL Studio Podcasts are available on EASL...

Emerging therapeutics based on gene addition, editing, or silencing are expected to change the landscape of genetic liver disease. Watch this episode to find out: Which approaches exist? Where are they in terms of preclinical and clinical development? How will they be used? Faculty Dr Mattias Mandorfer (Moderator) Dr Gloria Gonzalez-Aseguinolaza (Faculty) Prof. Pavel Strnad (Faculty) Prof. Man-Fun...

Ascites is the final consequence in a series of anatomic, pathophysiologic, and biochemical abnormalities and one of the most common complications of advanced cirrhosis. This EASL Studio will be discussing: Is it all about portal pressure? Which treatment option for which patient? Which trials are needed? Faculty Prof. Thomas Reiberger (Moderator) Prof. Benjamin Maasoumy (Faculty) Prof. Virginia H...

In honour of International Women’s day, this episode of EASL Studio will be raising awareness about the gender gap in academic research and debating how to improve gender diversity. Faculty Dr Johanne Poisson (Moderator) Prof. Eric Trépo (Moderator) Prof. Dina Balabanova (Faculty) Dr ‪Ea Høg Utoft‬ (Faculty) All EASL Studio Podcasts are available on EASL Campus .

Alcohol and food policies are increasingly being introduced to restrict marketing of and access to unhealthy foods. What impact will they have on consumption? How should they be implemented? How will they affect the incidence of liver and gastrointestinal diseases? Tune in to find out. Faculty Prof. Shira Zelber-Sagi (Moderator) Prof. Helena Cortez-Pinto (Faculty) Dr Sandro Demaio (Faculty) Prof....

Machine perfusion is changing the status quo in liver transplantation by optimising the use of organs in times of organ shortage. Watch this EASL Studio to: Better understand the role of machine perfusion in liver transplantation Understand the optimal situations in machine perfusion is beneficial Have an overview of the different types of machines under evaluation Faculty Prof. Marina Berenguer (...

The field of artificial Intelligence (AI) is rapidly growing and derived technologies are technologies are increasingly being used in medical sciences to improve patient outcomes. What exactly is AI? How can it be beneficial? Why should AI be used in medicine? Watch this EASL Studio to find out. Faculty Prof. Jakob Nikolas Kather (Moderator) Prof. Julien Calderaro (Faculty) Dr Arsela Prelaj (Facul...

Although there is an almost unanimous consensus on the prognostic weight of the term ‘decompensation’, a clear corresponding consensus on its definition is still lacking. In addition, classifying cirrhosis as compensated and decompensated oversimplifies the clinical course of the disease which encompasses many different groups. Faculty Prof. Paolo Angeli (Moderator) Prof. Guadalupe Garcia-Tsao (Fa...

Alcohol is the main cause of advanced liver disease and a major cause of hospitalisation and disability across the globe, including Europe. In this EASL Studio you will hear the patient perspective from an individual who has overcome this disease and listen to the faculty discuss the measures that can help prevent it. Faculty Prof. Ramon Bataller (Moderator) Prof. Giovanni Addolorato (Faculty) Pro...